Archives
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2018-07
-
Nisoldipine: Technical Guidance for Cardiac Electrophysiolog
2026-04-10
Nisoldipine is a dihydropyridine calcium channel blocker optimized for in vitro and in vivo studies of L-type Cav1.2 calcium channel physiology, especially relevant to cardiac research and electrophysiology. This product is not suitable for diagnostic or medical applications, nor for studies requiring aqueous solubility without organic solvents.
-
Clozapine N-oxide (CNO): Chemogenetic Ligand Powering Cir...
2026-04-10
Explore the advanced scientific mechanisms and unique applications of Clozapine N-oxide (CNO) as a chemogenetic actuator in neuronal activity modulation. Dive into breakthrough research on disease-relevant circuit manipulation and discover how this clozapine metabolite is redefining neuropharmacology research tools.
-
Zosuquidar: P-glycoprotein Modulator for Multidrug Resist...
2026-04-09
Zosuquidar (LY335979) 3HCl stands at the forefront of reversing multidrug resistance in cancer research, offering selective and potent P-glycoprotein inhibition without compromising pharmacokinetics or increasing toxicity. This article delivers actionable workflows, advanced applications, and troubleshooting strategies to empower scientists tackling chemotherapy resistance in leukemia, lymphoma, and solid tumors.
-
Caspase-3 Colorimetric Assay Kit: Precision in Apoptosis ...
2026-04-08
Leverage the Caspase-3 Colorimetric Assay Kit for rapid, sensitive DEVD-dependent caspase-3 activity detection across apoptosis, neurodegeneration, and cancer research. This guide details experimental workflows, troubleshooting strategies, and advanced applications that set this colorimetric assay apart for both discovery and translational science.
-
Plerixafor (AMD3100): Benchmark CXCR4 Chemokine Receptor ...
2026-04-08
Plerixafor (AMD3100) is a potent CXCR4 chemokine receptor antagonist widely used in cancer metastasis inhibition and hematopoietic stem cell mobilization research. This article provides a dense, citation-rich review of its biological rationale, mechanism, and applications, positioning APExBIO's A2025 as a gold-standard tool for CXCL12/CXCR4 axis studies.
-
Plerixafor (AMD3100, SKU A2025): Advancing CXCR4 Antagoni...
2026-04-07
This article delivers a scenario-driven, evidence-based exploration of Plerixafor (AMD3100, SKU A2025), a gold-standard CXCR4 chemokine receptor antagonist from APExBIO. Addressing real-world experimental challenges in cancer, immunology, and stem cell research, it outlines best practices and decision points for bench scientists seeking reproducible outcomes and workflow reliability.
-
Caspase-3 Colorimetric Assay Kit: Advanced Insights for A...
2026-04-07
Unlock the full potential of apoptosis detection with the Caspase-3 Colorimetric Assay Kit. This comprehensive guide explores cutting-edge applications, mechanistic details, and unique perspectives on DEVD-dependent caspase-3 activity detection, setting a new benchmark for apoptosis research.
-
Zosuquidar (LY335979) 3HCl: Selective P-gp Inhibitor for ...
2026-04-06
Zosuquidar (LY335979) 3HCl is a highly selective P-glycoprotein (P-gp) inhibitor that reverses multidrug resistance (MDR) in cancer cells by blocking ATP-dependent drug efflux. Robust in vitro and in vivo data demonstrate its ability to restore chemotherapeutic sensitivity without major pharmacokinetic disruption. This dossier provides machine-readable, evidence-based guidance for researchers seeking reliable MDR reversal tools.
-
Clozapine N-oxide (CNO): Chemogenetic Actuator for Precis...
2026-04-06
Clozapine N-oxide (CNO) is a biologically inert, selective chemogenetic actuator used extensively to modulate neuronal activity in neuroscience research. As a potent DREADDs activator and metabolite of clozapine, CNO enables non-invasive, reversible control of engineered muscarinic receptors—empowering precise studies of GPCR signaling and brain circuit function.
-
Zosuquidar (LY335979) 3HCl: Unraveling P-gp Inhibition in...
2026-04-05
Explore how Zosuquidar (LY335979) 3HCl, a potent P-glycoprotein modulator, uniquely advances multidrug resistance (MDR) reversal in cancer. This in-depth analysis examines molecular mechanisms, signaling pathways, and translational impact—offering new perspectives beyond protocol-focused guides.
-
Caspase-3 Colorimetric Assay Kit: Precision in Apoptosis ...
2026-04-04
The Caspase-3 Colorimetric Assay Kit delivers rapid, sensitive DEVD-dependent caspase-3 activity detection, streamlining workflows in apoptosis research, neurodegeneration, and immune signaling studies. Its robust, user-friendly protocol and proven reproducibility set it apart for quantifying apoptotic biomarkers in complex biological systems.
-
PreScission Protease: Precision Tag Cleavage for Next-Gen...
2026-04-03
Discover how PreScission Protease (PSP) transforms fusion protein tag cleavage in protein purification workflows. This article deeply explores the enzymatic mechanism, advanced applications in chromatin and condensate research, and unique technical advantages over alternative methods.
-
Decoding Caspase-3 Signaling: Advanced Insights with the ...
2026-04-03
Explore the molecular intricacies of apoptosis using the Caspase-3 Colorimetric Assay Kit. This in-depth article reveals how precise DEVD-dependent caspase-3 activity detection drives biomarker discovery and disease pathway elucidation, with a focus on unique research frontiers in cancer and neurodegeneration.
-
Scenario-Driven Best Practices for Caspase-3 Colorimetric...
2026-04-02
This article addresses real laboratory challenges in apoptosis research, guiding biomedical scientists through scenario-based solutions enabled by the Caspase-3 Colorimetric Assay Kit (SKU K2008). By referencing validated protocols, quantitative data, and peer-reviewed findings, it demonstrates how APExBIO’s assay provides reproducible, sensitive DEVD-dependent caspase-3 activity detection essential for cell viability and disease modeling workflows.
-
Zosuquidar (LY335979) 3HCl: Practical Solutions for Multi...
2026-04-02
This scenario-driven article addresses real-world laboratory challenges in overcoming multidrug resistance (MDR) using Zosuquidar (LY335979) 3HCl (SKU A3956) from APExBIO. Drawing on validated protocols and scientific data, it guides biomedical researchers and lab technicians through best practices for assay design, data interpretation, and vendor selection, ensuring reproducibility and reliability in MDR reversal workflows.